관상동맥 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Coronary Arteries Stent Market size is expected to reach USD 18.72 Billion in 2034 from USD 10.34 Billion (2025) growing at a CAGR of 6.82% during 2026-2034.

The global coronary arteries stent market is experiencing strong growth due to the increasing prevalence of cardiovascular diseases. Coronary stents are used to open blocked arteries and restore blood flow, reducing the risk of heart attacks. The growing aging population and rising incidence of lifestyle-related diseases are key factors driving market expansion. Additionally, advancements in medical technology are improving stent performance and patient outcomes.

Key growth drivers include the increasing adoption of minimally invasive procedures and the development of drug-eluting stents. These stents reduce the risk of restenosis and improve long-term outcomes. The expansion of healthcare infrastructure and increasing access to advanced cardiac care are also contributing to market growth. Furthermore, rising awareness about heart health and early diagnosis is supporting demand.

In the future, the coronary arteries stent market is expected to grow significantly with continuous innovation in cardiovascular treatments. The development of bioresorbable and next-generation stents will further enhance adoption. Emerging markets are likely to provide substantial growth opportunities due to improving healthcare systems. Additionally, ongoing research and development will continue to drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Bare Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

By Material

• Metallic
• Polymer-Based

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers

COMPANIES PROFILED

• Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Biotronik SE Co KG, B Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Biosensors International Group, Ltd, Cook Medical Inc, C R Bard, Inc, Elixir Medical Corporation, Stentys SA, Lepu Medical Technology Beijing Co, Ltd, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORONARY ARTERIES STENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Bare Metal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug-Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORONARY ARTERIES STENT MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Polymer-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORONARY ARTERIES STENT MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORONARY ARTERIES STENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Material
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Material
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Material
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Material
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Material
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CORONARY ARTERIES STENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Abbott Laboratories
  • 9.2.3 Medtronic Plc
  • 9.2.4 Biotronik SE & Co. KG
  • 9.2.5 B. Braun Melsungen AG
  • 9.2.6 Terumo Corporation
  • 9.2.7 MicroPort Scientific Corporation
  • 9.2.8 Biosensors International GroupLtd
  • 9.2.9 Cook Medical Inc
  • 9.2.10 C. R. BardInc
  • 9.2.11 Elixir Medical Corporation
  • 9.2.12 Stentys SA
  • 9.2.13 Lepu Medical Technology (Beijing) Co.Ltd
  • 9.2.14 Sahajanand Medical Technologies Pvt. Ltd
  • 9.2.15 Meril Life Sciences Pvt. Ltd